Kalaris Therapeutics (NASDAQ:KLRS) Director Acquires $5,000,005.74 in Stock
Kalaris Therapeutics Inc. (NASDAQ:KLRS - Get Free Report) Director Srinivas Akkaraju acquired 479,847 shares of the stock in a transaction dated Thursday, December 18th. The shares were purchased at...